Skip to main content
PRFX
NASDAQ Life Sciences

FDA Clears PRF Technologies' OcuRing™-K for Phase II Trial in Post-Cataract Pain, Advancing Key Drug Candidate

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$2.06
Mkt Cap
$1.934M
52W Low
$1.797
52W High
$17.95
52W Position info
15% above low
Off High info
89% below high
Rel. Volume
Market data snapshot near publication time

PRFX is trading near its 52-week low of $1.797 (15% above the low).

Summary

PRF Technologies announced that the FDA has cleared its Investigational New Drug (IND) application for OcuRing™-K, enabling the initiation of a Phase II clinical trial. OcuRing™-K is a novel, drop-less, sustained-release ocular drug-delivery platform designed to address post-cataract pain and inflammation. This regulatory clearance is a significant milestone for the clinical-stage company, de-risking the asset and advancing a key product candidate into the next stage of clinical development. For a company of this size, progressing to Phase II is a crucial step towards potential market entry in the large cataract surgery market. Investors will now monitor the planned initiation of the multi-center Phase II trial in the second half of 2026 and subsequent data readouts.

At the time of this announcement, PRFX was trading at $2.06 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.9M. The 52-week trading range was $1.80 to $17.95. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

PRFX - Latest Insights

PRFX
Nov 13, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.7834
Real-time Price: $0.61715 info
Change: -$0.16625 (-21%) info
Market Cap: $1.877M info
PRFX
Nov 12, 2026, 4:31 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.7354
Real-time Price: $0.61715 info
Change: -$0.11825 (-16%) info
Market Cap: $1.877M info
PRFX
Nov 12, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.786
Real-time Price: $0.61715 info
Change: -$0.16885 (-21%) info
Market Cap: $1.877M info
PRFX
Nov 05, 2026, 4:15 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.7588
Real-time Price: $0.61715 info
Change: -$0.14165 (-19%) info
Market Cap: $1.877M info
PRFX
Nov 03, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.7705
Real-time Price: $0.61715 info
Change: -$0.15335 (-20%) info
Market Cap: $1.877M info